Annual Drug Patent Expirations for FYCOMPA
Fycompa is a drug marketed by Catalyst Pharms and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for FYCOMPA.
This drug has ninety-three patent family members in thirty-three countries.
The generic ingredient in FYCOMPA is perampanel. Two suppliers are listed for this compound. Additional details are available on the perampanel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
